This page shows Phenixfin (PFXNZ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Phenixfin passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.
For every $1 of reported earnings, Phenixfin generates $-16.20 in operating cash flow (-$67.3M OCF vs $4.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Phenixfin reported $4.2M in net income in fiscal year 2025. This represents a decrease of 77.7% from the prior year.
Phenixfin earned $2.06 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 77.4% from the prior year.
Phenixfin held $7.3M in cash against $0 in long-term debt as of fiscal year 2025.
Phenixfin had 2M shares outstanding in fiscal year 2025. This represents a decrease of 0.8% from the prior year.
Phenixfin's ROE was 2.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 9.0 percentage points from the prior year.
Phenixfin spent $801K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 66.2% from the prior year.
PFXNZ Income Statement
| Metric | Q1'26 | Q1'25 | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $360K | N/A | $398K+29.5% | $308K+38.8% | $222K | N/A | $227K-27.0% | $311K |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $2.4M | N/A | $2.7M+3.1% | $2.6M+1.3% | $2.5M | N/A | $1.7M+9.9% | $1.6M |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$4.8M | N/A | -$1.5M-67.1% | -$896K-136.4% | $2.5M | N/A | $2.6M-51.4% | $5.4M |
| EPS (Diluted) | $-2.38 | N/A | $-0.74-68.2% | $-0.44-136.1% | $1.22 | N/A | $1.29-50.8% | $2.62 |
PFXNZ Balance Sheet
| Metric | Q1'26 | Q1'25 | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $307.4M-3.0% | $316.9M+3.3% | $306.8M+2.0% | $300.7M-3.6% | $311.9M+3.0% | $302.8M+22.9% | $246.3M-0.6% | $247.7M |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $3.4M-53.4% | $7.3M0.0% | $7.3M-16.1% | $8.7M+20.8% | $7.2M-89.3% | $67.6M+659.6% | $8.9M-53.4% | $19.1M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $151.6M-2.9% | $156.1M+4.0% | $150.1M+5.9% | $141.7M-5.0% | $149.2M+4.7% | $142.4M+54.7% | $92.1M-1.4% | $93.4M |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $155.8M-3.1% | $160.8M+2.6% | $156.7M-1.4% | $159.0M-2.3% | $162.8M+1.5% | $160.3M+4.0% | $154.2M0.0% | $154.3M |
| Retained Earnings | -$548.6M-0.9% | -$543.9M+0.6% | -$547.4M-0.3% | -$545.9M-0.7% | -$542.1M+0.5% | -$544.6M-1.2% | -$538.2M0.0% | -$538.2M |
PFXNZ Cash Flow Statement
| Metric | Q1'26 | Q1'25 | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.0M+31.5% | -$3.0M+56.8% | -$6.9M-178.2% | $8.8M+113.3% | -$66.3M-860.7% | $8.7M+204.7% | -$8.3M-192.9% | $9.0M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | -$1.8M-161.6% | $3.0M-45.2% | $5.5M+174.9% | -$7.3M-223.8% | $5.9M-88.2% | $50.0M+2680.6% | -$1.9M+3.6% | -$2.0M |
| Dividends Paid | N/A | $0 | $0 | N/A | N/A | $0 | N/A | N/A |
| Share Buybacks | $183K+3731.5% | $5K | N/A | N/A | N/A | $0-100.0% | $31K-98.3% | $1.8M |
PFXNZ Financial Ratios
| Metric | Q1'26 | Q1'25 | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | 1.5% | N/A | 1.7%-1.8pp | 3.5% |
| Return on Assets | -1.6% | N/A | -0.5%-0.2pp | -0.3%-1.1pp | 0.8% | N/A | 1.1%-1.1pp | 2.2% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 0.970.0 | 0.97+0.0 | 0.96+0.1 | 0.89-0.0 | 0.92+0.0 | 0.89+0.3 | 0.600.0 | 0.61 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Frequently Asked Questions
Is Phenixfin profitable?
Yes, Phenixfin (PFXNZ) reported a net income of $4.2M in fiscal year 2025.
What is Phenixfin's earnings per share (EPS)?
Phenixfin (PFXNZ) reported diluted earnings per share of $2.06 for fiscal year 2025. This represents a -77.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Phenixfin's return on equity (ROE)?
Phenixfin (PFXNZ) has a return on equity of 2.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Phenixfin's operating cash flow?
Phenixfin (PFXNZ) generated -$67.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Phenixfin's total assets?
Phenixfin (PFXNZ) had $316.9M in total assets as of fiscal year 2025, including both current and long-term assets.
Does Phenixfin buy back shares?
Yes, Phenixfin (PFXNZ) spent $801K on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
How many shares does Phenixfin have outstanding?
Phenixfin (PFXNZ) had 2M shares outstanding as of fiscal year 2025.
What is Phenixfin's debt-to-equity ratio?
Phenixfin (PFXNZ) had a debt-to-equity ratio of 0.97 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Phenixfin's return on assets (ROA)?
Phenixfin (PFXNZ) had a return on assets of 1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Phenixfin's cash runway?
Based on fiscal year 2025 data, Phenixfin (PFXNZ) had $7.3M in cash against an annual operating cash burn of $67.3M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Phenixfin's Piotroski F-Score?
Phenixfin (PFXNZ) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Phenixfin's earnings high quality?
Phenixfin (PFXNZ) has an earnings quality ratio of -16.20x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.